(Q68699110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

Phase 2 study of mitozantrone in combination with chlorambucil and prednisolone for relapsed and refractory non-Hodgkins lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference

Jones L

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Cotter FE

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Lord D

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Newland AC

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

41-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

Follicular lymphoma: prognostic factors for response and survival

26 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

Mitoxantrone in malignant lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

Mitoxantrone induced congestive heart failure in patients previously treated with anthracyclines

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

Non-Hodgkin's lymphomas. II. Single agent chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

Clinical studies of ABMT in non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

Mitoxantrone (novantrone): a review of experimental and early clinical studies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900080106

7 January 2021

Identifiers

DOI

10.1002/HON.2900080106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2298419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference